Back to top
more

Doximity (DOCS)

(Delayed Data from NYSE)

$24.27 USD

24.27
1,092,518

+0.45 (1.89%)

Updated Apr 29, 2024 04:00 PM ET

After-Market: $24.25 -0.02 (-0.08%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (81 out of 252)

Industry: Medical Services

Better trading starts here.

Zacks News

Zacks Industry Outlook Highlights Elevance Health Medpace and Doximity

Elevance Health, Medpace and Doximity are part of the Zacks Industry Outlook article.

Urmimala Biswas headshot

3 Medical Services Industry Stocks to Buy as Nursing Market Booms

The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. ELV, MEDP and DOCS are set to gain the most. However, staffing shortages continue to put brakes on growth.

Is Janus Henderson Small Cap Growth Alpha ETF (JSML) a Strong ETF Right Now?

Smart Beta ETF report for JSML

SGRY vs. DOCS: Which Stock Should Value Investors Buy Now?

SGRY vs. DOCS: Which Stock Is the Better Value Option?

Down -6.99% in 4 Weeks, Here's Why You Should You Buy the Dip in Doximity (DOCS)

The heavy selling pressure might have exhausted for Doximity (DOCS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

All You Need to Know About Doximity (DOCS) Rating Upgrade to Buy

Doximity (DOCS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ICLR vs. DOCS: Which Stock Is the Better Value Option?

ICLR vs. DOCS: Which Stock Is the Better Value Option?

Compared to Estimates, Doximity (DOCS) Q3 Earnings: A Look at Key Metrics

The headline numbers for Doximity (DOCS) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Doximity (DOCS) Q3 Earnings and Revenues Surpass Estimates

Doximity (DOCS) delivered earnings and revenue surprises of 20.83% and 6.14%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Countdown to Doximity (DOCS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Get a deeper insight into the potential performance of Doximity (DOCS) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Doximity (DOCS) Upgraded to Buy: What Does It Mean for the Stock?

Doximity (DOCS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Industry Outlook Highlights Medpace, Doximity and Biodesix

Medpace, Doximity and Biodesix have been highlighted in this Industry Outlook article.

Earnings Estimates Moving Higher for Doximity (DOCS): Time to Buy?

Doximity (DOCS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Urmimala Biswas headshot

3 Medical Services Stocks to Buy as Industry Trends Improve

The Zacks Medical - Services industry is growing on digital healthcare adoption. MEDP, DOCS and BDSX are set to gain the most. However, staffing shortages may disrupt the growth trend.

ICLR or DOCS: Which Is the Better Value Stock Right Now?

ICLR vs. DOCS: Which Stock Is the Better Value Option?

Doximity (DOCS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Doximity (DOCS) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Doximity (DOCS) Reports Next Week: Wall Street Expects Earnings Growth

Doximity (DOCS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Implied Volatility Surging for Doximity (DOCS) Stock Options

Investors need to pay close attention to Doximity (DOCS) stock based on the movements in the options market lately.

MD or DOCS: Which Is the Better Value Stock Right Now?

MD vs. DOCS: Which Stock Is the Better Value Option?

Implied Volatility Surging for Doximity (DOCS) Stock Options

Investors need to pay close attention to Doximity (DOCS) stock based on the movements in the options market lately.

Here's What Key Metrics Tell Us About Doximity (DOCS) Q1 Earnings

While the top- and bottom-line numbers for Doximity (DOCS) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Doximity (DOCS) Surpasses Q1 Earnings and Revenue Estimates

Doximity (DOCS) delivered earnings and revenue surprises of 26.67% and 1.40%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

DocGo Inc. (DCGO) Reports Q2 Loss, Tops Revenue Estimates

DocGo Inc. (DCGO) delivered earnings and revenue surprises of -166.67% and 4.89%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Avantor, Inc. (AVTR) Misses Q2 Earnings and Revenue Estimates

Avantor, Inc. (AVTR) delivered earnings and revenue surprises of -3.45% and 3.06%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?